After Biden’s win, all eyes remain on Covid-19 and the recovery

After Biden’s win, all eyes remain on Covid-19 and the recovery

04-12-2020 | Insight
Joe Biden has been elected 46th US President, based on vote count. Despite President Donald Trump not having conceded defeat yet, the transition has started and the real uncertainty lies in the control of the Senate, which will not be known until Georgia’s run-off elections on 5 January 2021. We believe the probability of a split Congress is high.
  • Fabiana Fedeli
    Global Head of Fundamental Equities

Speed read

  • A likely split Congress will limit Biden’s ability to implement new policies
  • Implementation of a US stimulus package will be crucial in the short term
  • Covid-19 and recovery to remain more important than US policy changes
Stay informed on our latest insights with monthly mail updates
Stay informed on our latest insights with monthly mail updates

As the new administration moves in amid a pandemic, three elements matter for equity investors. First, the policies that a Biden administration will be able to implement. Second, the developments on the Covid-19 front. Closely related to this is the third element, which is the ability of the US economy to maintain and possibly extend its recovery.

With a split Congress, the power of the new administration to implement new policies will be severely curtailed. Past US administrations have become well versed in the art of governing through executive orders. Yet, when it comes to changing legislation, loosening the purse strings, as well as key Cabinet and federal agency appointments, the President needs a collaborative Senate. Given the extreme divide along party lines, we see limited room for bipartisan support.

Hence, the Biden administration is likely to be less about what it will deliver and more about what it will not disrupt compared to a Trump White House. With or without support of the Senate, we expect a Biden administration to be less confrontational on the foreign policy front and less keen to use tariffs as its weapon of choice.

A Biden administration is likely to be less about what it will deliver and more about what it will not disrupt compared to a Trump White House.

This would be positive for international trade and relations, and would improve market sentiment towards Europe and emerging markets. A Biden Presidency is also expected to create far less volatility in investors’ sentiment on China. A Democratic White House would likely be a tough negotiator with China, but also a more consistent one, compared to the current administration.

And while there are unlikely to be trillions of dollars spent on climate change, let alone the introduction of a carbon tax, the focus on sustainability in the US is likely to increase. Biden can rejoin the Paris Agreement on climate change without support of the Senate. And, with or without Congress backing, environmental awareness in the US is rising.

One area where we are likely to see more emphasis from a Biden administration is the regulatory pressure on large internet and cloud platforms. While there is bipartisan consensus on the need to rein in some of the perceived power of large players, disagreement on how such regulation should materialize and the complexity of updating current US antitrust rules mean that it is unlikely that new regulation will be implemented any time soon. Yet, scrutiny on Big Tech is destined to increase and a Biden administration would still be able to pursue Department of Justice lawsuits, occasionally rattling markets.

For equity markets, in the near term the most relevant outcome of a Biden administration with a divided Congress is the absence of a timely and substantial fiscal stimulus package, which will most likely slow down the recovery of the US economy.

This makes the successful management of the Covid-19 outbreak in the US and the timely availability of effective therapies and vaccines even more crucial. And while US investors may feel relieved that much feared financial regulation and tax increases are now unlikely to be implemented, in the end it will be the economic recovery or lack thereof that will set the course for US equities.

‘Our base case remains that the global economy will continue to improve, but the improvement will be uneven among countries’

For us, this means that equity markets outside the US offer more attractive opportunity potential from a cost-reward perspective – in other words, considering valuations versus potential upside. In fact, our base case remains that the global economy will continue to improve, but that the improvement will be uneven among countries. Those where Covid-19 and its impact on the economy is more contained should see a positive effect on corporate fundamentals and on their equity markets.

It will not be plain sailing. It never is. Any news on therapeutic breakthroughs, the speed at which the virus spreads and the likely timing of the distribution of a vaccine can generate significant mood swings. We should also expect some volatile news flow from the incumbent US administration until 20 January 2021.

President Trump is unlikely to gracefully concede defeat and could try to implement last-minute controversial policies. However, barring any unforeseen and irreversible measures, we believe that US and global equity markets are for the most part likely to look through the news flow from the White House over the next two months and trade on the basis of what is expected to come next.

We do not see any reason to change our investment allocations based on the expected outcome of the US elections. We believe that the progression of the Covid-19 outbreak across the world and the likely path of economic recovery ahead will be far more significant for global equity markets than any likely US policy changes.

Our investment teams have continued to selectively take profit from growth/defensive stocks with stretched valuations across global equities and have added to quality laggards that are expected to benefit from recovery in some (but not all) areas of the economy. We see the light at the end of the tunnel. While a second Covid-19 wave is slowing down the global economic recovery, we are now getting closer to the end of the sources of uncertainty, as we see a path towards the approval of Covid-19 vaccines and more therapies.

In addition, the valuation disparity between growth/defensive stocks and their cyclical/value counterparties have reached levels that often appear unhinged from fundamentals. Importantly, stock selection for us remains key as some companies will be structurally damaged by the protracted impact of Covid-related restrictions.

At a regional level, North Asia including China, Taiwan and South Korea is the largest overweight position in our global portfolios, followed by Europe. We have recently reduced our underweight in Japan and have moved to a small underweight in our US exposure.

Within emerging markets, we remain selective at a country level. We have continued to increase our positions in China, Taiwan and South Korea, and we are overall cautious on Latin American and EMEA economies. However, more recently, we have seen some improvements regarding the pandemic in a number of emerging countries outside of North Asia, and this is paired with improvements in the economic data. These developments may warrant a change in investment positioning in the near future.

From a sector standpoint, Technology stocks remain an overweight in many portfolios. This is true also for US technology, although we have been actively reducing the position. The US tech megacaps are still underpinned by strong earnings momentum, but valuations are stretched for many them. The initial activity jolt from the ‘work from home’ phenomenon has now passed and comparisons will become more demanding from 2Q21 onwards.

Since the summer, we have been increasing our exposure to industrial stocks, specialty materials and consumer names across the US, Europe and North Asia. Within the industrial sector, we particularly like the theme of lower climate impact and increased energy efficiency, as we see rising awareness and investments in this area.

We also like the US pharmaceutical sector. Even after the recent improvement in performance, valuations are close to an all-time-high discount relative to the S&P 500 Index, with otherwise healthy fundamentals and solid pipelines.

Our investment considerations are based on our expectation of a Biden administration governing with a split Congress. Such outcome would change if the Georgia Senate run-off turns in the Democratic party’s favor. More stimulus, environmental policies and changes to the US healthcare system than we expect now would be the most likely consequence.

The direction and speed of travel of equity markets, first and foremost in the US, but also globally, would be affected. For now, we see this as a less likely scenario. Yet, nothing can and should be discounted in equity markets. Never a dull moment.

Important information

The contents of this document have not been reviewed by the Securities and Futures Commission ("SFC") in Hong Kong. If you are in any doubt about any of the contents of this document, you should obtain independent professional advice. This document has been distributed by Robeco Hong Kong Limited (‘Robeco’). Robeco is regulated by the SFC in Hong Kong.
This document has been prepared on a confidential basis solely for the recipient and is for information purposes only. Any reproduction or distribution of this documentation, in whole or in part, or the disclosure of its contents, without the prior written consent of Robeco, is prohibited. By accepting this documentation, the recipient agrees to the foregoing
This document is intended to provide the reader with information on Robeco’s specific capabilities, but does not constitute a recommendation to buy or sell certain securities or investment products. Investment decisions should only be based on the relevant prospectus and on thorough financial, fiscal and legal advice. Please refer to the relevant offering documents for details including the risk factors before making any investment decisions.
The contents of this document are based upon sources of information believed to be reliable. This document is not intended for distribution to or use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation.
Investment Involves risks. Historical returns are provided for illustrative purposes only and do not necessarily reflect Robeco’s expectations for the future. The value of your investments may fluctuate. Past performance is no indication of current or future performance.

Subjects related to this article are:


1. General
Please read this information carefully.

This website is prepared and issued by Robeco Hong Kong Limited ("Robeco"), which is a corporation licensed by the Securities and Futures Commission in Hong Kong to engage in Type 1 (dealing in securities); Type 4 (advising in securities) and Type 9 (asset management) regulated activities. The Company does not hold client assets and is subject to the licensing condition that it shall seek the SFC’s prior approval before extending services at retail level. This website has not been reviewed by the Securities and Futures Commission or any regulatory authority in Hong Kong.

2. Important risk disclosures
2. Important risk disclosures Robeco Capital Growth Funds (“the Funds”) are distinguished by their respective specific investment policies or any other specific features. Please read carefully for the risks of the Funds:

  • Some Funds are subject to investment, market, equities, liquidity, counterparty, securities lending and foreign currency risk and risk associated with investments in small and/or mid-capped companies.
  • Some Funds are subject to the risks of investing in emerging markets which include political, economic, legal, regulatory, market, settlement, execution, counterparty and currency risks.
  • Some Funds may invest in China A shares directly through the Qualified Foreign Institutional Investor (“QFII”) scheme and / or RMB Qualified Foreign Institutional Investor (“RQFII”) scheme and / or Stock Connect programmes which may entail additional clearing and settlement, regulatory, operational, counterparty and liquidity risk.
  • For distributing share classes, some Funds may pay out dividend distributions out of capital. Where distributions are paid out of capital, this amounts to a return or withdrawal of part of your original investment or capital gains attributable to that and may result in an immediate decrease in the net asset value of shares.
  • Some Funds’ investments maybe concentrated in one region / one country / one sector / around one theme and therefore the value of the Fund may be more volatile and may be subject to concentration risk.
  • The risk exists that the quantitative techniques used by some Funds may not work and the Funds’ value may be adversely affected.
  • In addition to investment, market, liquidity, counterparty, securities lending, (reverse) repurchase agreements and foreign currency risk, some Funds are subject to risk associated with fixed income investments like credit risk, interest rate risk, convertible bonds risk, ABS risk and the risk of investments in non-investment grade or unrated securities and the risk of investments made in non-investment grade sovereign securities.
  • Some Funds can use derivatives extensively. Robeco Global Consumer Trends Equities can use derivatives for hedging and efficient portfolio management. Derivatives exposure may involve higher counterparty, liquidity and valuation risks. In adverse situations, the Funds may suffer significant losses (even a total loss of the Funds’ assets) from its derivative usage.
  • Robeco European High Yield Bonds is subject to Eurozone risk.
  • Investors may suffer substantial losses of their investments in the Funds. Investor should not invest in the Funds solely based on the information provided in this document and should read the offering documents (including potential risks involved) for details.

3. Local legal and sales restrictions
The Website is to be accessed by “professional investors” only (as defined in the Securities and Futures Ordinance (Cap.571) and/or the Securities and Futures (Professional Investors) Rules (Cap.571D) under the laws of Hong Kong). The Website is not directed at any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Website is prohibited. Persons in respect of whom such prohibitions apply or persons other than those specified above must not access this Website. Persons accessing the Website need to be aware that they are responsible themselves for the compliance with all local rules and regulations. By accessing this Website and any of its pages, you acknowledge your agreement with understanding of the following terms of use and legal information. If you do not agree to the terms and conditions below, do not access this Website or any pages thereof.

The information contained in the Website is being provided for information purposes.

Neither information nor any opinion expressed on the Website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. The information contained in the Website does not constitute investment advice or a recommendation and was prepared without regard to the specific objectives, financial situation or needs of any particular person who may receive it. An investment in a Robeco product should only be made after reading the related legal documents such as management regulations, prospectuses, most recent annual and semi-annual reports, which can be all be obtained free of charge at www.robeco.com/hk/en and at the Robeco Hong Kong office.

4. Use of the Website
The information is based on certain assumptions, information and conditions applicable at a certain time and may be subject to change at any time without notice. Robeco aims to provide accurate, complete and up-to-date information, obtained from sources of information believed to be reliable. Persons accessing the Website are responsible for their choice and use of the information.

5. Investment performance
No assurance can be given that the investment objective of any investment products will be achieved. No representation or promise as to the performance of any investment products or the return on an investment is made. The value of your investments may fluctuate. The value of the assets of Robeco investment products may also fluctuate as a result of the investment policy and/or the developments on the financial markets. Results obtained in the past are no guarantee for the future. Past performance, projection, or forecast included in this Website should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Fund performance figures are based on the month-end trading prices and are calculated on a total return basis with dividends reinvested. Return figures versus the benchmark show the investment management result before management and/or performance fees; the fund returns are with dividends reinvested and based on net asset values with prices and exchange rates of the valuation moment of the benchmark.
Investments involve risks. Past performance is not a guide to future performance. Potential investors should read the terms and conditions contained in the relevant offering documents and in particular the investment policies and the risk factors before any investment decision is made. Investors should ensure they fully understand the risks associated with the fund and should also consider their own investment objective and risk tolerance level. Investors are reminded that the value and income (if any) from shares of the fund may be volatile and could change substantially within a short period of time, and investors may not get back the amount they have invested in the fund. If in doubt, please seek independent financial and professional advice.

6. Third party websites
This website includes material from third parties or links to websites maintained by third parties some of which is supplied by companies that are not affiliated to Robeco. Following links to any other off-site pages or websites of third parties shall be at the own risk of the person following such link. Robeco has not reviewed any of the websites linked to or referred to by the Website and does not endorse or accept any responsibility for their content nor the products, services or other items offered through them. Robeco shall have no liability for any losses or damages arising from the use of or reliance on the information contained on websites of third parties, including, without limitation, any loss of profit or any other direct or indirect damage. Third party off-site pages or websites are provided for informational purposes only.

7. Limitation of liability
Robeco as well as (possible) other suppliers of information to the Website accept no responsibility for the contents of the Website or the information or recommendations contained herein, which moreover may be changed without notice.
Robeco assumes no responsibility for ensuring, and makes no warranty, that the functioning of the Website will be uninterrupted or error-free. Robeco assumes no responsibility for the consequences of e-mail messages regarding a Robeco (transaction) service, which either cannot be received or sent, are damaged, received or sent incorrectly, or not received or sent on time.
Neither will Robeco be liable for any loss or damage that may result from access to and use of the Website.

8. Intellectual property
All copyrights, patents, intellectual and other property, and licenses regarding the information on the Website are held and obtained by Robeco. These rights will not be passed to persons accessing this information.

9. Privacy
Robeco guarantees that the data of persons accessing the Website will be treated confidentially in accordance with prevailing data protection regulations. Such data will not be made available to third parties without the approval of the persons accessing the Website, unless Robeco is legally obliged to do so. Please find more details in our Privacy and Cookie Policy.

10. Applicable law
The Website shall be governed by and construed in accordance with the laws of Hong Kong. All disputes arising out of or in connection with the Website shall be submitted to the exclusive jurisdiction of the courts of Hong Kong. 

Please click the “I agree” button if you have read and understood this page and agree to the Disclaimers above and the collection and use of your personal data by Robeco, for the purposes for which such data is collected and used as set out in the Privacy and Cookie Policy, including for the purpose of direct marketing of Robeco products or services. Otherwise, please click “I Disagree” to leave the website.

I Disagree